NIP
TECX

Nicholas Investment Partners’s Tectonic Therapeutic TECX Stock Holding History

Nicholas Investment Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-586
Closed -$365K – 243
2018
Q3 		$365K Buy
+586
New +$260K 0.03% 212

Other funds holding TECX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nicholas Investment Partners's TECX Position: Q4 2018 in Review

Nicholas Investment Partners sold out of Tectonic Therapeutic (TECX) in Q4 2018, closing a stake of 586 shares — an estimated $365K sold.

Nicholas Investment Partners first reported a position in TECX in Q3 2018 and held it in 1 quarter. The position peaked at $365K in Q3 2018. 59 funds tracked by Wall St. Rank hold TECX as of Q4 2018.

  • Nicholas Investment Partners reported no remaining Tectonic Therapeutic position as of Q4 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 586 Tectonic Therapeutic shares in Q4 2018, an estimated $365K.
  • Nicholas Investment Partners first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 1 quarter.
  • Nicholas Investment Partners's Tectonic Therapeutic position peaked at $365K in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2018.

Based on Nicholas Investment Partners's 13F filing for Q4 2018, filed 14 Feb 2019.